kenacomb
pharmacy retailing (nz) ltd t/a healthcare logistics - gramicidin 0.25 mg/g; neomycin sulfate 2.5 mg/g; nystatin 100000 u/g ((+ 5% excess, approx 35mg/g)); triamcinolone acetonide 1 mg/g ((3% manufacturing overage)) - ear drops - active: gramicidin 0.25 mg/g neomycin sulfate 2.5 mg/g nystatin 100000 u/g ((+ 5% excess, approx 35mg/g)) triamcinolone acetonide 1 mg/g ((3% manufacturing overage)) excipient: liquid paraffin polyethylene - the topical treatment of superficial bacterial infections, cutaneous candidosis and dermatological conditions known to respond to topical steroid therapy when threatened or complicated by bacterial or candidal superinfections, especially otitis externa.
kenacort
aspen pharma pty ltd - triamcinolone acetonide -
kenacort a10
aspen pharma pty ltd - triamcinolone acetonide -
kenacort a40
aspen pharma pty ltd - triamcinolone acetonide -
kenacomb
pharmacy retailing (nz) ltd t/a healthcare logistics - gramicidin 0.25 mg/g; neomycin sulfate 2.5 mg/g; nystatin 100000 u/g; triamcinolone acetonide 1 mg/g - topical ointment - active: gramicidin 0.25 mg/g neomycin sulfate 2.5 mg/g nystatin 100000 u/g triamcinolone acetonide 1 mg/g - kenacomb is indicated for the relief of the inflammatory and pruritic manifestations of dermatoses likely to become or which are already infected.
kenacort-t 40 mg/ml injektionsvätska, suspension
kenacort-t 40 mg/ml injektionsvätska, suspension
kenacomb cream
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide nystatin neomycin sulfate gramicidin - cream - 15 grams